Quantcast

Posts related to ‘OREX’

pills

Arena Withdraws Application for Weight-Loss Drug Approval in Europe

Posted: May 3, 2013 at 8:30 am

Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) has withdrawn its application for European regulatory approval of its weight-loss drug Belviq. The drug was approved for use in the United States ...
Read Full Story »
biotech

Top Biotech-Pharma Stock Ideas with Continued Big Upside (OREX, HALO, BAX, BMRN)

Posted: March 28, 2013 at 8:50 am

Much of the research coverage on Wall St. from the bulge bracket firms is concentrated on the most liquid, best known stocks from the S&P 500. These names are recognizable ...
Read Full Story »
76764023

VIVUS Obesity Drug Sales Only About 60% of Expectations

Posted: February 25, 2013 at 5:08 pm

VIVUS Inc. (NASDAQ: VVUS) reported a quarterly loss of $0.56 per share on Monday, but this was not an earnings story. VIVUS remains a developing story about its obesity drug ...
Read Full Story »
76764023

Europe Denies Obesity Drug Approval

Posted: February 21, 2013 at 5:20 pm

If you are obese in Europe, you are not about to get a little pill to take to help you change. You will just have to lose that weight the old-fashioned ...
Read Full Story »
76764023

Positive Clinical Study Could Provide a Tailwind for Obesity Drugs (VVUS, ARNA, OREX)

Posted: February 1, 2013 at 9:04 am

According to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese or very overweight. Obesity-related medical conditions include heart attack, ...
Read Full Story »
76764023

Arena Risk: Possible Drag on All Weight-Loss Drugs

Posted: January 22, 2013 at 1:21 pm

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) is posing yet one more threat to ambitious biotechs and drug-makers who are targeting the obesity market. Its stock is getting slapped by almost 10% ...
Read Full Story »
76764023

The Obesity Drug Stock Rally Has Started (OREX, ARNA, VVUS, BAC)

Posted: January 16, 2013 at 8:16 am

Back in December, we took an in-depth look at what has become a crowded race in the obesity drug market. As we pointed out then, the race has become a ...
Read Full Story »
76764023

Is There Finally a Winner in the Crowded Obesity Drug Market?

Posted: December 18, 2012 at 10:43 am

According to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke, type-2 diabetes ...
Read Full Story »

Top Analyst Upgrades and Downgrades (ATVI, ARNA, BCS, EAT, CIT, CLF, ESRX, MWW, NBR, NOK, NVO, OREX, PBY, GOLD, SWK, STI, VPRT, KEY)

Posted: September 6, 2012 at 8:15 am

These are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Thursday. Activision Blizzard Inc. (NASDAQ: ATVI) raised to Overweight at Piper Jaffray. ...
Read Full Story »

Weight Loss Drugs Eating Up FDA Approval

Posted: July 18, 2012 at 9:05 am

The history of weight loss drugs is sketchy at best. But VIVUS Inc. (NASDAQ: VVUS) is making up on all of its recent losses, after shares slid from almost $30 ...
Read Full Story »

Today’s Standout Winners and Losers

Posted: June 28, 2012 at 11:16 am

The Dow Jones Industrial Average, Nasdaq and S&P 500 are all down more than 1% Thursday morning, with banks and health insurance stocks down the most in the broader market. Nevertheless, the big ...
Read Full Story »

Top Analyst Upgrades & Downgrades (AAPL, BDN, CHTR, CSCO, DELL, DRIV, F, HW, HPQ, IBM, NTAP, OREX, QCOM, RIMM, CNK, RGC)

Posted: June 28, 2012 at 8:39 am

These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Thursday. Anadarko Petroleum Corporation (NYSE: APC) Raised to Outperform at Bernstein. Apple ...
Read Full Story »

Arena Obesity Pill Approved, Good For All Fat-Fighters (ARNA, VVUS, OREX, AGN)

Posted: June 27, 2012 at 1:22 pm

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) was halted today for news that the company's weight-loss drug called BELVIQ has been approved.  The news is good for all obesity drug makers today.  ...
Read Full Story »

Arena Volume Spike Highlights Weight Loss Sector Again, Volatility To Continue (ARNA, VVUS, OREX)

Posted: June 13, 2012 at 12:55 pm

We are tracking and analyzing a significant volume spike in shares of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today.  Shares are up nearly 5% at $8.25 and the 12:30 PM trading ...
Read Full Story »

NASDAQ Changes Up Biotech Index Members & Weightings

Posted: May 14, 2012 at 7:59 am

Index changes are generally speaking a fairly routine event.  They can also create underlying moves in the companies added and deleted from them as money management firms often buy and ...
Read Full Story »